fresh debates in ACT have shown tha...

fresh debates in ACT have shown that random imbalance in clinical trials is a topic of lively suit at law (1-3) During my interactions with trialists in industry, academia, and the public health sector, I have draw near across what I believe are serious misunderstandings regarding what randomization can and cannot do to underwrite the validity of statistical inferences from clinical trials. In this commentary I use games of chance to attempt a simple explanation of the issues.

I believe there are pair misunderstood points regarding randomization. First, randomization in clinical